Cargando…
High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for Prophylaxis
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619234/ https://www.ncbi.nlm.nih.gov/pubmed/36325270 http://dx.doi.org/10.1097/HS9.0000000000000793 |
| _version_ | 1784821230544617472 |
|---|---|
| author | te Linde, Elsemieke Boots, Laura J. E. Daenen, Laura G. M. de Witte, Moniek A. Bruns, Anke H. W. |
| author_facet | te Linde, Elsemieke Boots, Laura J. E. Daenen, Laura G. M. de Witte, Moniek A. Bruns, Anke H. W. |
| author_sort | te Linde, Elsemieke |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9619234 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96192342022-11-01 High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for Prophylaxis te Linde, Elsemieke Boots, Laura J. E. Daenen, Laura G. M. de Witte, Moniek A. Bruns, Anke H. W. Hemasphere Letter Lippincott Williams & Wilkins 2022-10-26 /pmc/articles/PMC9619234/ /pubmed/36325270 http://dx.doi.org/10.1097/HS9.0000000000000793 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Letter te Linde, Elsemieke Boots, Laura J. E. Daenen, Laura G. M. de Witte, Moniek A. Bruns, Anke H. W. High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for Prophylaxis |
| title | High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for Prophylaxis |
| title_full | High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for Prophylaxis |
| title_fullStr | High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for Prophylaxis |
| title_full_unstemmed | High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for Prophylaxis |
| title_short | High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for Prophylaxis |
| title_sort | high incidence of herpes zoster in patients using ruxolitinib for myeloproliferative neoplasms: need for prophylaxis |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619234/ https://www.ncbi.nlm.nih.gov/pubmed/36325270 http://dx.doi.org/10.1097/HS9.0000000000000793 |
| work_keys_str_mv | AT telindeelsemieke highincidenceofherpeszosterinpatientsusingruxolitinibformyeloproliferativeneoplasmsneedforprophylaxis AT bootslauraje highincidenceofherpeszosterinpatientsusingruxolitinibformyeloproliferativeneoplasmsneedforprophylaxis AT daenenlauragm highincidenceofherpeszosterinpatientsusingruxolitinibformyeloproliferativeneoplasmsneedforprophylaxis AT dewittemonieka highincidenceofherpeszosterinpatientsusingruxolitinibformyeloproliferativeneoplasmsneedforprophylaxis AT brunsankehw highincidenceofherpeszosterinpatientsusingruxolitinibformyeloproliferativeneoplasmsneedforprophylaxis |